The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Oncogenes and Tumor Suppressor Genes
Open accessAbstract
Breast cancer progression involves multiple genetic events, which can activate dominant-acting oncogenes and disrupt the function of specific tumor suppressor genes. This article describes several key oncogene and tumor suppressor signaling networks that have been implicated in breast cancer progression. Among the tumor suppressors, the article emphasizes BRCA1/2 and p53 tumor suppressors. In addition to these well characterized tumor suppressors, the article highlights the importance of PTEN tumor suppressor in counteracting PI3K signaling from activated oncogenes such as ErbB2. This article discusses the use of mouse models of human breast that recapitulate the key genetic events involved in the initiation and progression of breast cancer. Finally, the therapeutic potential of targeting these key tumor suppressor and oncogene signaling networks is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Bunting, S. F., Callén, E., Wong, N., Chen, H.-T., Polato, F., Gunn, A., Bothmer, A., Feldhahn, N., Fernandez-Capetillo, O., Cao, L., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.012 · Cited by 1,671
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 2×
“active and its deletion results in embryonic lethality (reviewed in Donehower and Lozano 2009; Kruse and Gu 2009).”
BackgroundkConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492 · cited 1×
“This highlights the haplo-insufficiency phenotype of BRCA1 in mammary epithelial differentiation (Lim et al. 2009).”
BackgroundWeaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“Deletion of TP53 rescues embryonic lethality in Mdm2- and Mdm4-deficient mice (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001).”
BackgroundCreighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1×
“Deletion of TP53 rescues embryonic lethality in Mdm2- and Mdm4-deficient mice (Jones et al. 1995; Montes de Oca Luna et al. 1995; Parant et al. 2001).”
BackgroundBond, G. L., Hu, W., Bond, E. E., Robins, H., Lutzker, S. G., Arva, N. C., Bargonetti, J., Bartel, F., Taubert, H., Wuerl, P., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.022 · Cited by 1,265
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Self-citationSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 1×
“For example, genes that encode enzymes involved in histone modification are mutated in primary renal cell carcinoma (Dalgliesh et al. 2010; van Haaften et al. 2009).”
BackgroundMuller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,165
Self-citationGenome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Hirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., & Berns, A. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,053
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
The biology of erbB-2/nue/HER-2 and its role in cancer
Hynes, N. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 971
Rottenberg, S., Jaspers, J. E., Kersbergen, A., van der Burg, E., Nygren, A. O. H., Zander, S. A. L., Derksen, P. W. B., de Bruin, M., Zevenhoven, J., Lau, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806092105 · Cited by 956
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · cited 2×
“To prevent cancer recurrence, new strategies such as targeting of DNA repair pathways, reactivating p53 (reviewed in Brown et al. 2009; Shangary and Wang 2009), and inhibiting cancer stem cells, are being developed.”
BackgroundThe BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
Complex landscapes of somatic rearrangement in human breast cancer genomes
Stephens, P. J., McBride, D. J., Lin, M.-L., Varela, I., Pleasance, E. D., Simpson, J. T., Stebbings, L. A., Leroy, C., Edkins, S., Mudie, L. J., et al. (2009) · Nature · doi:10.1038/nature08645 · Cited by 845
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784
Xu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
The transcriptional repressor Snail promotes mammary tumor recurrence
Moody, S. E., Perez, D., Pan, T.-C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.009 · Cited by 750
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P.-L., Lee, W.-H., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 705
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., Brisken, C., Minucci, S., Di Fiore, P. P., & Pelicci, P. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.048 · Cited by 696
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Sy, S. M. H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 614
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00048-0 · Cited by 613
Atchley, D. P., Albarracin, C. T., Lopez, A., Valero, V., Amos, C. I., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Arun, B. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6231 · Cited by 604
Moro, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 584
Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers
Lee, E. Y.-H. P., To, H., Shew, J.-Y., Bookstein, R., Scully, P., & Lee, W.-H. (1988) · Science · doi:10.1126/science.3388033 · Cited by 581
Self-citationTumor Suppressive Functions of p53
Zilfou, J. T., & Lowe, S. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001883 · Cited by 575
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Visvader, J. E. (2009) · Genes & Development · doi:10.1101/gad.1849509 · Cited by 571
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 562
Wong, A. K. C., Pero, R., Ormonde, P. A., Tavtigian, S. V., & Bartel, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.31941 · Cited by 539
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517
Ten Genes for Inherited Breast Cancer
Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477
Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 474
BRCA1 regulates human mammary stem/progenitor cell fate
Liu, S., Ginestier, C., Charafe-Jauffret, E., Foco, H., Kleer, C. G., Merajver, S. D., Dontu, G., & Wicha, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711613105 · Cited by 461
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., & Giancotti, F. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.047 · Cited by 455
Self-citationHarvey, D. M., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.12b.2375 · Cited by 453
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100566997 · Cited by 444
Chen, P. L., Riley, D. J., Chen, Y., & Lee, W. H. (1996) · Genes & Development · doi:10.1101/gad.10.21.2794 · Cited by 442
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Andrulis, I. L., Bull, S. B., Blackstein, M. E., Sutherland, D., Mak, C., Sidlofsky, S., Pritzker, K. P., Hartwick, R. W., Hanna, W., Lickley, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1340 · Cited by 441
Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
Matsui, Y., Halter, S. A., Holt, J. T., Hogan, B. L. M., & Coffey, R. J. (1990) · Cell · doi:10.1016/0092-8674(90)90077-r · Cited by 440
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Song, H., Hollstein, M., & Xu, Y. (2007) · Nature Cell Biology · doi:10.1038/ncb1571 · Cited by 439
Improved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
Requirement for CDK4 kinase function in breast cancer
Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
Self-citationDasika, G. K., Lin, S.-C. J., Zhao, S., Sung, P., Tomkinson, A., & Lee, E. Y.-H. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203283 · Cited by 427
Self-citationWhite, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413
Self-citationBulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E., & Fornace, A. J. (2004) · Nature Genetics · doi:10.1038/ng1317 · Cited by 409
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan, S. F., Lee, S. Y., Chen, G., Song, M., Tomlinson, G. E., & Lee, E. Y.-H. P. (1999) · PubMed · Cited by 404
Self-citationStructural Rearrangement of the Retinoblastoma Gene in Human Breast Carcinoma
T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L., & Fung, Y.-K. T. (1988) · Science · doi:10.1126/science.3175651 · Cited by 403
Chen, P.-L., Chen, C.-F., Chen, Y., Xiao, J., Sharp, Z. D., & Lee, W.-H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5287 · Cited by 394
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
Bouchard, L., Lamarre, L., Tremblay, P. J., & Jolicoeur, P. (1989) · Cell · doi:10.1016/0092-8674(89)90331-0 · Cited by 393
Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth
Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., & Inoue, S. (2002) · Nature · doi:10.1038/nature00826 · Cited by 357
Saal, L. H., Gruvberger-Saal, S. K., Persson, C., Lövgren, K., Jumppanen, M., Staaf, J., Jönsson, G., Pires, M. M., Maurer, M., Holm, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.39 · Cited by 355
Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Byrski, T., Huzarski, T., Dent, R., Gronwald, J., Zuziak, D., Cybulski, C., Kladny, J., Gorski, B., Lubinski, J., & Narod, S. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0128-9 · Cited by 340
Prevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
Self-citationCyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Park, S. Y., Gönen, M., Kim, H. J., Michor, F., & Polyak, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40724 · Cited by 324
The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer
Dillon, R. L., White, D. E., & Muller, W. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210202 · Cited by 311
Self-citationCancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors
Shafee, N., Smith, C. R., Wei, S., Kim, Y., Mills, G. B., Hortobagyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 308
Self-citationEGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes
Mariotti, A., Kedeshian, P. A., Dans, M., Curatola, A. M., Gagnoux-Palacios, L., & Giancotti, F. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105017 · Cited by 305
Wu-Baer, F., Lagrazon, K., Yuan, W., & Baer, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300249200 · Cited by 302
Sur, S., Pagliarini, R., Bunz, F., Rago, C., Diaz, L. A., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813333106 · Cited by 295
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276
Wang, F., Hansen, R. K., Radisky, D., Yoneda, T., Barcellos-Hoff, M. H., Petersen, O. W., Turley, E. A., & Bissell, M. J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1494 · Cited by 270
Pylayeva, Y., Gillen, K. M., Gerald, W., Beggs, H. E., Reichardt, L. F., & Giancotti, F. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37160 · Cited by 261
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
Pegram, M. D., Pauletti, G., & Slamon, D. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006111117877 · Cited by 259
Ravdin, P. M., & Chamness, G. C. (1995) · Gene · doi:10.1016/0378-1119(94)00866-q · Cited by 254
Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3465 · Cited by 251
Self-citationWang, Y., Yang, J., Zheng, H., Tomasek, G. J., Zhang, P., McKeever, P. E., Lee, E. Y.-H. P., & Zhu, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.001 · Cited by 250
Self-citationMaroulakou, I. G., Oemler, W., Naber, S. P., & Tsichlis, P. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3782 · Cited by 238
Zheng, L., Pan, H., Li, S., Flesken-Nikitin, A., Chen, P.-L., Boyer, T. G., & Lee, W.-H. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00075-7 · Cited by 232
Cancer. p53 Guardian of the Genome
Rokudai, S. (2017) · The KITAKANTO Medical Journal · doi:10.2974/kmj.67.63 · Cited by 232
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
Andrechek, E. R., Hardy, W. R., Siegel, P. M., Rudnicki, M. A., Cardiff, R. D., & Muller, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3444 · Cited by 230
Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.735 · Cited by 228
Self-citationHwang-Verslues, W. W., Kuo, W.-H., Chang, P.-H., Pan, C.-C., Wang, H.-H., Tsai, S.-T., Jeng, Y.-M., Shew, J.-Y., Kung, J. T., Chen, C.-H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008377 · Cited by 223
Self-citationAutoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase
Chen, A., Kleiman, F. E., Manley, J. L., Ouchi, T., & Pan, Z.-Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201252200 · Cited by 217
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Siegel, P. M., Dankort, D. L., Hardy, W. R., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7068 · Cited by 213
Self-citationLuo, M., Fan, H., Nagy, T., Wei, H., Wang, C., Liu, S., Wicha, M. S., & Guan, J.-L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3078 · Cited by 208
MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells
Iliopoulos, D., Polytarchou, C., Hatziapostolou, M., Kottakis, F., Maroulakou, I. G., Struhl, K., & Tsichlis, P. N. (2009) · Science Signaling · doi:10.1126/scisignal.2000356 · Cited by 206
Guy, C. T., Muthuswamy, S. K., Cardiff, R. D., Soriano, P., & Muller, W. J. (1994) · Genes & Development · doi:10.1101/gad.8.1.23 · Cited by 203
Self-citationAkt1 governs breast cancer progression in vivo
Ju, X., Katiyar, S., Wang, C., Liu, M., Jiao, X., Li, S., Zhou, J., Turner, J., Lisanti, M. P., Russell, R. G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605874104 · Cited by 200
Prognostic factors in early breast carcinoma
Mansour, E. G., Ravdin, P. M., & Dressier, L. (1994) · Cancer · doi:10.1002/cncr.2820741326 · Cited by 199
Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression
Lahlou, H., Sanguin-Gendreau, V., Zuo, D., Cardiff, R. D., McLean, G. W., Frame, M. C., & Muller, W. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710091104 · Cited by 196
Self-citationMuraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C.-X. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Function of the Zinc-Finger Transcription Factor SNAI2 in Cancer and Development
Cobaleda, C., Pérez-Caro, M., Vicente-Dueñas, C., & Sánchez-García, I. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130146 · Cited by 174
High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer
Holstege, H., Joosse, S. A., van Oostrom, C. T. M., Nederlof, P. M., de Vries, A., & Jonkers, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3426 · Cited by 171
Dillon, R. L., Marcotte, R., Hennessy, B. T., Woodgett, J. R., Mills, G. B., & Muller, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4287 · Cited by 169
Self-citation20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2731 · Cited by 168
Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1540-1551.2001 · Cited by 163
Self-citationBRCA2: a universal recombinase regulator
Thorslund, T., & West, S. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210870 · Cited by 161
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Ursini‐Siegel, J., Hardy, W. R., Zuo, D., Lam, S. H. L., Sanguin‐Gendreau, V., Cardiff, R. D., Pawson, T. J., & Muller, W. J. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.22 · Cited by 158
Self-citationProteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter‐Edouart, A., Lemoine, J., Bourhis, X. L., Hornez, L., Boilly, B., Nurcombe, V., Révillion-Carette, F., Peyrat, J., & Hondermarck, H. (2001) · PubMed · Cited by 157
Sandgren, E. P., Schroeder, J. A., Qui, T. H., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1995) · PubMed · Cited by 157
Muller, W. J., Arteaga, C. L., Muthuswamy, S. K., Siegel, P. M., Webster, M. A., Cardiff, R. D., Meise, K. S., Li, F., Halter, S. A., & Coffey, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5726 · Cited by 147
Self-citationActivated neu Induces Rapid Tumor Progression
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7673 · Cited by 145
Self-citationA mouse model of basal‐like breast carcinoma with metaplastic elements
McCarthy, A., Savage, K., Gabriel, A., Naceur‐Lombardelli, C., Reis‐Filho, J., & Ashworth, A. (2007) · The Journal of Pathology · doi:10.1002/path.2124 · Cited by 144
Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells
Furuta, S., Jiang, X., Gu, B., Cheng, E., Chen, P., & Lee, W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503793102 · Cited by 142
A novel splice variant ofHER2 with increased transformation activity
Kwong, K. Y., & Hung, M. (1998) · Molecular Carcinogenesis · Cited by 139
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Beggs, H. E., & Keely, P. J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080308 · Cited by 138
Wang, S. E., Xiang, B., Zent, R., Quaranta, V., Pozzi, A., & Arteaga, C. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2649 · Cited by 136
Johnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 134
Reim, F., Dombrowski, Y., Ritter, C., Buttmann, M., Häusler, S. F., Ossadnik, M., Krockenberger, M., Beier, D., Beier, C. P., Dietl, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0834 · Cited by 129
Lenferink, A. E. G., Simpson, J. F., Shawver, L. K., Coffey, R. J., Forbes, J. T., & Arteaga, C. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160564197 · Cited by 124
Lin, S. J., Lee, K., Nikitin, A. Y., Hilsenbeck, S. G., Cardiff, R. D., Li, A., Kang, K.-W., Frank, S. A., Lee, W., & Lee, E. Y.-H. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3524 · Cited by 123
Self-citationMuraoka, R. S., Lenferink, A. E. G., Law, B. K., Hamilton, E., Brantley, D. M., Roebuck, L. R., & Arteaga, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2204-2219.2002 · Cited by 116
Huber, L. J., Yang, T. W., Sarkisian, C. J., Master, S. R., Deng, C., & Chodosh, L. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4005-4015.2001 · Cited by 112
Our changing view of the genomic landscape of cancer
Bell, D. W. (2009) · The Journal of Pathology · doi:10.1002/path.2645 · Cited by 110
Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
Ludwig, T. E., Fisher, P. E., Murty, V. V., & Efstratiadis, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204512 · Cited by 105
Siegel, P. M., & Muller, W. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8878 · Cited by 104
Self-citationMuthuswamy, S. K., & Wj, M. (1995) · PubMed · Cited by 101
Delayed mammary gland involution in MMTV-AKT1 transgenic mice
Ackler, S., Ahmad, S., Tobias, C. A., Johnson, M. D., & Glazer, R. I. (2002) · Oncogene · doi:10.1038/sj.onc.1205052 · Cited by 95
Montagna, C., Andrechek, E. R., Padilla‐Nash, H. M., Muller, W. J., & Ried, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205146 · Cited by 94
Self-citationTung, N., Wang, Y., Collins, L. C., Kaplan, J., Li, H., Gelman, R. S., Comander, A. H., Gallagher, B. M., Fetten, K., Krag, K. J., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2478 · Cited by 94
Ranger, J. J., Levy, D. E., Shahalizadeh, S., Hallett, M. T., & Muller, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1684 · Cited by 92
Self-citationAdelsman, M. A., McCarthy, J. B., & Shimizu, Y. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.9.2861 · Cited by 91
p53, cyclin-dependent kinase and abnormal amplification of centrosomes
Fukasawa, K. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.04.002 · Cited by 85
Brandt, R., Eisenbrandt, R., Leenders, F., Zschiesche, W., Binas, B., Juergensen, C., & Theuring, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203520 · Cited by 80
Muthuswamy, S. K., & Wj, M. (1995) · PubMed · Cited by 78
Schade, B., Rao, T., Dourdin, N., Lesurf, R., Hallett, M. T., Cardiff, R. D., & Muller, W. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018937 · Cited by 77
Self-citationTargeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth
Andrechek, E. R., White, D., & Muller, W. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208230 · Cited by 72
Self-citationBurga, L. N., Tung, N., Troyan, S. L., Bostina, M., Konstantinopoulos, P. A., Fountzilas, H., Spentzos, D., Miron, A., Yassin, Y., Lee, B. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2954 · Cited by 70
Kim, H. L., Chan, R., Dankort, D. L., Zuo, D., Naujokas, M. A., Park, M., & Muller, W. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208898 · Cited by 69
Self-citationInduction of genetic instability by gain-of-function p53 cancer mutants
Xu, Y. (2008) · Oncogene · doi:10.1038/sj.onc.1211023 · Cited by 63
Marcotte, R., Zhou, L., Kim, H. L., Roskelly, C. D., & Muller, W. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01731-08 · Cited by 62
Self-citationComen, E. A., & Robson, M. E. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79253-7 · Cited by 61
Dourdin, N., Schade, B., Lesurf, R., Hallett, M. T., Munn, R. J., Cardiff, R. D., & Muller, W. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5727 · Cited by 55
Self-citationA role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation
Li, W., Xiao, C., Vonderhaar, B. K., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210527 · Cited by 54
BRCT Domains: phosphopeptide binding and signaling modules
María, C. (2008) · Frontiers in bioscience · doi:10.2741/3125 · Cited by 52
Hodgson, J. G., Malek, T. B., Bornstein, S., Hariono, S., Ginzinger, D. G., Muller, W. J., & Gray, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0755 · Cited by 52
Self-citationPreclinical mouse models for BRCA1-associated breast cancer
Drost, R., & Jonkers, J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605350 · Cited by 48
Dillon, R. L., Brown, S. T., Ling, C., Shioda, T., & Muller, W. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00866-07 · Cited by 45
Self-citationAddressing the Role of Cell Adhesion in Tumor Cell Dormancy
White, D. E., Rayment, J. H., & Muller, W. J. (2006) · Cell Cycle · doi:10.4161/cc.5.16.2993 · Cited by 43
Self-citationCheung, A., Elia, A., Tsao, M., Done, S. J., Wagner, K., Hennighausen, L. G., Hakem, R., & Mak, T. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2270 · Cited by 38
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
Andrechek, E. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050408497 · Cited by 37
Antoniotti, S., Taverna, D., Maggiora, P., SAPEI, M. L., Hynes, N. E., & Bortoli, M. D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.454 · Cited by 32
Schade, B., Lam, S. H. L., Cernea, D. D., Sanguin‐Gendreau, V., Cardiff, R. D., Jung, B. L., Hallett, M. T., & Muller, W. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4724 · Cited by 30
Self-citationGetting to the Root of BRCA1-Deficient Breast Cancer
Ginestier, C., Liu, S., & Wicha, M. S. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.08.007 · Cited by 27
Gillgrass, A. E., Cardiff, R. D., Sharan, N., Kannan, S., & Muller, W. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206983 · Cited by 26
Self-citationPromotion of BRCA1-associated triple-negative breast cancer by ovarian hormones
Lee, E. Y.-H. P. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f42237 · Cited by 20
Self-citationKim, S. S., Cao, L., Baek, H. J., Lim, S., Li, C., Wang, R., Xu, X., Cho, K. H., & Deng, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2418 · Cited by 20
Stemming the Tide of Cancer for BRCA1/2 Mutation Carriers
Lynch, H. T., Marcus, J. N., & Rubinstein, W. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.4201 · Cited by 4
Cited by
Tumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedAnczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Elazezy, M., & Joosse, S. A. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.10.002 · Cited by 370
Diagnostic biosensors in medicine – A review
Metkar, S. K., & Girigoswami, K. (2019) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2018.11.029 · Cited by 304
Metadata
- Authors
- Lee, E. Y. H. P., & Muller, W. J.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-08-18
- Volume
- 2
- Issue
- 10
- Pages
- a003236-a003236
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W1966313764
- Cited by
- 508
- References
- 173
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.